Sterlite Grid 5Unlisted Shares
₹ 334▼3.19%(11.00)
About the company
Sterlite Grid 5 operates as a power-transmission infrastructure company under the broader Sterlite Power platform. Based on the descriptions across dealer listings, its business centers on:
Developing, owning, and operating high-voltage inter-state transmission assets in India, generally under a Build-Own-Operate-Maintain (BOOM) model — meaning it builds transmission lines/substations and then earns long-term, regulated revenue from operating them, rather than trading power.
Grid modernization, including smart-grid technology and real-time monitoring to improve reliability and operational efficiency.
Supporting renewable energy integration into the transmission network, positioning the company as part of India's broader energy-transition infrastructure buildout.
Regulatory compliance with bodies such as the Central Electricity Regulatory Commission (CERC), consistent with any regulated inter-state transmission licensee in India.
Importantly, SGL 5 is a transmission company, not a power generation company - it does not produce electricity; it moves it.
Fundamentals
Valuation
- 52 week high
- ₹385
- 52 week low
- ₹288
- P/B ratio
- 8.85
- Debt to equity
- 1
- ROE (%)
- -92.51%
- Book value
- ₹37.74
- Face value
- ₹2
- Valuation
- —
Registry
- PAN number
- AAXCS7626L
- ISIN number
- INE03QT01027
- CIN
- U29190PN2016PLC209044
Figures in cr ·
Financials
| P&L Statement | 2024 | 2025 |
|---|---|---|
| Revenue | 1246 | 1161 |
| EBITDA | 128 | 98 |
| OPM | 10.27 | 8.44 |
| PBT | -427 | -410 |
| PAT | -442 | -426 |
| EPS | -36.11 | -34.76 |
Frequently asked questions
Common questions on Sterlite Grid 5 Unlisted Shares—tap a row to read the answer.
Q.1Can I actually buy shares right now?
Yes. Several platforms and brokers who deal in unlisted shares facilitate these transactions. You'll typically need a demat account, since unlisted shares are also held in demat form, just like listed ones.
Q.2How is the price of an unlisted share decided?
There's no live ticker like you'd see for listed stocks. Prices are usually based on recent private deals, the company's financials, industry comparisons, and simple demand-supply among buyers and sellers on these platforms. Because of this, prices can vary a bit from one platform to another.
Q.3Is it risky to invest in unlisted shares?
Yes, more so than listed shares. A few things to keep in mind:
Liquidity risk – it can take longer to find a buyer when you want to sell, unlike listed shares which you can sell instantly.
Price transparency – there's no single "market price," so you're relying on the platform/broker's quote.
Limited information – unlisted companies don't have the same disclosure requirements as listed ones, so less public data is available.
Q.4What happens to my unlisted shares if the company eventually lists (IPO)?
If Sterlite Grid 5 does an IPO in the future, your unlisted shares typically convert to regular listed shares in your demat account, and you can then trade them on the exchange like any other stock.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
